Shenzhen HYK Gene Technology Co., Ltd. was founded;
the Group rolled out the first-generation homemade PSTAR-I high-throughput gene sequencing system;
Dr. Sheng Sitong was selected into the first batch of “The Thousand Talents Program” introduced by the State;
the Group realized localization of sequencing reagents;
the Group was awarded an honorary title of “Key Entrepreneur Team of Overseas Chinese Run Enterprise” by the Overseas Chinese Affairs Office of the State Council;
the Group was awarded the honorary title of “Demonstrative Base for Production-Academy-Research Integration of Ministries of Education and Science in Guangdong Province”;
the Group was awarded the honorary title of “Key Overseas Scientific Research and Innovation Team Introduced by Guangdong Province”;
the Group successfully developed the second-generation homemade PSTAR-II high-throughput gene sequencing system;
the “high-throughput gene sequencer” was certified as a “National Key New Product”;
the Group set up a “Post-doctor Work Station”;
the “Engineering Technology Center of High-throughput Gene Sequencing” of Shenzhen was established;
the Group was awarded the honorary title of “Demonstrative Base for Production-Academy-Research Integration of Ministries of Education and Science in Guangdong Province”;
HYK Gene acted as the leader unit of the first standardization work team in the field of gene sequencing-“Biological Method Team of National Commission of Bio-chemical Test Standardization Technology” (SAC/TC387/WG3);
the Group rolled out PSTAR-II A type gene sequencer for clinical application;
The Group successfully developed PSTAR-II plus high-throughput gene sequencing system;
the Group was approved to establish an “Academician Workstation of Microorganism Gene Analysis Technology of Shenzhen HYK of Guangdong”;
The Group was granted with a Medical Device Manufacturing Enterprise License;
the sequencing platform was granted with a Registration Certificate for Medical Devices;
The Group was certified as a “National High-tech Enterprise”;
five sequencing devices were granted with the Registration Certificate for Medical Devices;
The Group successfully developed SeqExpert-III A high-throughput gene sequencing system;
the first homemade gene sequencer HYK-PSTAR II-A was rated among the first batch of products to pass “Special Review for Innovative Medical Devices” of the State.
the first national standard in the field of gene sequencing in China, Technical Regulations of High-throughput Gene Sequencing, initiated by HYK Gene, was officially released.
the National 863 Program organized by HYK Gene was officially launched.
HYK-PSTAR II-A type gene sequencer was granted with the Registration Certificate for Medical Devices.
Human’s EGFR Gene Mutation Test Reagent Kit (High-throughput Sequencing Method) passed the special review for innovative medical devices;
Wuhan Considerin Gene Health Technology Co., Ltd. under the Group was established;
Central China Base for Equipment and Reagent R&D and Production was settled in Wuhan Optics Valley.
Guangzhou Considerin Med Lab was granted with a Business Permit for Medical Institution.
Dr. Sheng Sitong, the Group’s chief scientist, was honored as a national leading talent of “Urban Partner of Wuhan”;
the Group signed a strategic alliance cooperation agreement with Vishuo in Singapore to co-build a model of “gene sequencing+ precision medicine data” and started its international cooperation;
HYK-PSTAR-IIA type high-throughput gene sequencer and sample pre-treatment device passed CE certification;